Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Health Yuan: Notice of Approval for Clinical Trial of a New Generation Glucocorticoid Drug
Health元 announced that recently, the company received the “Approval Notification for Drug Clinical Trials” issued by the National Medical Products Administration, approving the company’s new generation of corticosteroids (ICS) to conduct clinical trials. JKN2404 inhalation suspension is an independently developed innovative drug of a new generation of locally acting, highly selective small molecule corticosteroids (ICS), intended for the treatment of bronchial asthma and other respiratory diseases.